Every 10-Q that Cirtran (CIRX) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow CIRX and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full CIRX filings page.
CIRTRAN CORP (CIRX) reported sharply higher activity for the six months ended June 30, 2026. Net sales rose to $2.33 million from $0.63 million a year earlier, driven mainly by increased demand for HUSTLER-branded vapor products under its GloBrands distribution agreement. Gross profit increased to $1.08 million, and income from operations turned positive at $196,750 versus a prior-period operating loss of $236,531.
Despite the operating improvement, continuing operations still produced a net loss of $161,254, and overall net income of $2.11 million was mainly due to a $2.32 million gain from writing off time-barred debt in discontinued operations. CirTran remains highly leveraged, with total assets of $2.60 million versus total liabilities of $25.60 million, including $2.60 million of convertible debentures and $2.33 million of derivative liabilities.
Working capital was deeply negative, with a working capital deficit of about $20.3 million and cash of only $158,137. Management disclosed that these conditions raise substantial doubt about the company’s ability to continue as a going concern and plans to rely on revenue growth, cost controls, related-party advances, and additional financing. Management also concluded its disclosure controls and procedures were not effective as of June 30, 2026.
CirTran Corporation reported Q1 2026 net sales of $1,161,353, up sharply from $460,816 a year earlier, as demand for its HUSTLER-branded vapor products increased. Gross profit rose to $463,382, and loss from continuing operations narrowed to $65,737.
Overall net income reached $2,220,701, mainly from a $2,286,438 gain related to discontinued operations after writing off time-barred debt. Despite this accounting gain, CirTran carried a working capital deficit of about $20.2 million, total stockholders’ deficit of $22,886,494, and an accumulated deficit of $60,125,000 as of March 31, 2026.
Management disclosed that these conditions raise substantial doubt about the company’s ability to continue as a going concern and noted heavy use of related-party advances, substantial derivative liabilities, and significant accrued payroll and royalty obligations while disclosure controls and procedures were deemed not effective.
CirTran Corporation (CIRX) reported another quarterly loss and remains financially distressed. For the three months ended September 30, 2025, net sales rose to $448,492 from $256,070, mainly from stronger vapor product sales, lifting gross profit to $177,826. For the nine months, revenue was broadly flat at $1,077,743, while gross profit fell to $533,062 as costs increased.
The nine‑month net loss narrowed to $1,138,064 from $1,814,150, helped by lower derivative valuation losses, but interest expense of $612,219 and a derivative loss of $34,552 still weighed on results. Cash from operations was negative $1,031,790 and was covered largely by related‑party loans of $1,051,064.
At September 30, 2025, total assets were $1.9 million against liabilities of $27.5 million, including a working capital deficit of about $22.9 million, accumulated deficit of $62.8 million, and derivative liabilities of $2.49 million. Management states these conditions raise substantial doubt about the company’s ability to continue as a going concern, and disclosure controls and procedures were deemed not effective.